ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Articles tagged "Lymphoproliferative disease"

  • 2020 American Transplant Congress

    The FcγRIIIa-158 VV Genotype Increased the Risk of Post-Transplant Lymphoproliferative Disorder in T-Cell Depleted Kidney Transplant Recipients

    P. Gatault1, L. Lajoie1, J. Stojanova2, P. Marquet2, G. Thibault1

    1CHU Tours, Tours, France, 2CHU Limoges, Limoges, France

    *Purpose: Post-transplantation lymphoproliferative disorder (PTLD) is a severe complication in organ transplant recipients. The use of T lymphocyte-depleting antibodies (TLDAb), especially rabbit TLDAb contributes to…
  • 2019 American Transplant Congress

    Clinicopathologic Assessment of Monoclonal Immunoglobulin (Ig) Associated Renal Disease in the Kidney Allograft

    J. Kamal1, R. J. Crew1, X. Ye2, J. Swanson3, G. Appel1, G. Markowitz4, V. D'Agati4, I. Batal4

    1Nephrology, Columbia Unversity Medical Center, NEW YORK, NY, 2Nephrology, Hartford Hospital, Hartford, CT, 3Surgery, Christiana Hospital, Newark, DE, 4Pathology, Columbia Unversity Medical Center, NEW YORK, NY

    *Purpose: Monoclonal (M)Ig-associated renal disease comprises a group of disorders caused by paraproteins. Little is known about this entity in the renal allograft, as it…
  • 2019 American Transplant Congress

    Long-term Outcomes And The Feasibility Of Kidney Retransplantation In Pediatric Survivors Of Post-transplant Lymphoproliferative Disease

    S. Kizilbash, P. Verghese, B. Chavers

    University of Minnesota, Minneapolis, MN

    *Purpose: Post-transplant lymphoproliferative disease (PTLD) is a serious and life-threatening complication of solid organ transplantation. Long-term graft outcomes and the feasibility of kidney retransplantation in…
  • 2019 American Transplant Congress

    Quantitative Epstein-Barr Virus Viral Load Monitoring in Pediatric Kidney Transplantation

    C. Metran1, M. E. Araujo1, R. Cardoso1, G. Araujo1, T. De Paula1, L. Cristofani2, F. Penteado3, M. F. Pereira3, A. Watanabe1

    1Pediatric Nephrology, ICr HC FMUSP, São Paulo, Brazil, 2Pediatric Oncology, ICr HC FMUSP, São Paulo, Brazil, 3Pediatric Infectology, ICr HC FMUSP, São Paulo, Brazil

    *Purpose: Epstein Barr virus (EBV) belongs to the family of herpesvirus and is associated with a wide range of malignancies, including post-transplant lymphoproliferative disorder (PTLD).…
  • 2019 American Transplant Congress

    Post-Transplant Lymphoproliferative Disorders in Pediatric Renal Transplant Recipients: Case Series of 5 Patients

    M. E. Araujo1, C. Metran1, R. Cardoso1, G. Araujo1, T. De Paula1, L. Cristofani2, M. F. Pereira3, D. David4, A. Watanabe1

    1Pediatric Nephrology, ICr HC FMUSP, São Paulo, Brazil, 2Pediatric Oncology, ICr HC FMUSP, São Paulo, Brazil, 3Pediatric Infectology, ICr HC FMUSP, São Paulo, Brazil, 4Anatomopathology, HC FMUSP, São Paulo, Brazil

    *Purpose: Post-transplant Lymphoproliferative Disorders (PTLD) after solid organ transplantation is a complication of chronic immunosuppression (IS) and is generally associated with Epstein Barr virus (EBV)…
  • 2019 American Transplant Congress

    Post-Transplant Lymphoproliferative Disorders after Living-Donor Liver Transplantation: A Retrospective Cohort Study in 1,900 Cases of Single Center Experience

    T. Tajima1, K. Hata1, H. Haga2, M. Nishikori3, J. Kusakabe1, I. Tamaki1, T. Ito1, T. Kaido1, A. Takaori-Kondo3, S. Uemoto1

    1Div. of HBP Surgery and Transplantation, Dept. of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2Dept. of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 3Dept. of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan

    *Purpose: Post-transplant lymphoproliferative disorders (PTLD) is relatively rare but the most common, life-threatening neoplasms after organ transplantation. Because of their heterogeneity from benign to malignant…
  • 2019 American Transplant Congress

    Retrospective Nested Case Control Study of the Impact of Immunosuppression on Post Transplant Malignancy among Adult Heart Transplant Patients

    S. Crow, R. J. Bubik, S. S. Kushwaha, K. C. Mara, R. A. Dierkhising, N. L. Pereira

    Mayo Clinic, Rochester, MN

    *Purpose: Post-transplant malignancy is diagnosed in approximately 18% of heart transplant (HTx) recipients and is a leading long-term cause of death among these patients. The…
  • 2018 American Transplant Congress

    Cancer Incidence after Kidney Transplantation in Saudi Arabia, Comparing Different Induction Agents

    H. AlEid, S. Raza, T. Ali, I. Alahmadi, S. Aleid, D. Broering.

    Kidney and Pancreas Transplantation, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.

    Cancer incidence varies among different induction agents and different population. We aim to compare the incidence of cancer post kidney transplantation among different induction agents…
  • 2018 American Transplant Congress

    Long-Term Follow-Up of Pediatric Kidney Recipients Who Received Alemtuzumab Induction

    D. Harriman, A. Chen, J. Rogers, R. Stratta, G. Orlando, A. South, J-.J. Lin, A. Farney.

    Surgery, Pediatrics, Cardiovascular Sciences Center, Wake Forest Baptist Medical Center, Winston-Salem, NC.

    Introduction: Experience with alemtuzumab (alem) depleting antibody induction has rarely been studied in the pediatric population, and reports that exist have limited follow-up. The purpose…
  • 2017 American Transplant Congress

    Incidence of Late-Onset Complications Related to Immunosuppressive Drugs Following Adult to Adult Living Donor Liver Transplantation, Especially Focusing on De Novo Malignancy.

    S. Mizuno, Y. Iizawa, H. Kato, Y. Murata, A. Tanemura, N. Kuriyama, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.

    Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan

    Objectives:In patients with living donor liver transplantation (LDLT), late-onset complications sometimes develop and most of them are related to immunosuppressive drugs.Patients and Methods:In151 patients (25…
  • 1
  • 2
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time

        Visit Our Partner Sites

        American Transplant Congress (ATC)

        Visit the official site for the American Transplant Congress »

        American Journal of Transplantation

        The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

        American Society of Transplantation (AST)

        An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

        American Society of Transplant Surgeons (ASTS)

        The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

        Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

        Privacy Policy | Terms of Use

        This site uses cookies: Find out more.